MXPA05009712A - Composiciones que comprenden acido hialuronico para la prevencion de infecciones urogenitales. - Google Patents

Composiciones que comprenden acido hialuronico para la prevencion de infecciones urogenitales.

Info

Publication number
MXPA05009712A
MXPA05009712A MXPA05009712A MXPA05009712A MXPA05009712A MX PA05009712 A MXPA05009712 A MX PA05009712A MX PA05009712 A MXPA05009712 A MX PA05009712A MX PA05009712 A MXPA05009712 A MX PA05009712A MX PA05009712 A MXPA05009712 A MX PA05009712A
Authority
MX
Mexico
Prior art keywords
compositions
hyaluronic acid
prevention
urogenital infections
infections
Prior art date
Application number
MXPA05009712A
Other languages
English (en)
Inventor
Yang Shu-Ping
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of MXPA05009712A publication Critical patent/MXPA05009712A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/84—Accessories, not otherwise provided for, for absorbent pads
    • A61F13/8405—Additives, e.g. for odour, disinfectant or pH control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/20—Tampons, e.g. catamenial tampons; Accessories therefor
    • A61F13/2051—Tampons, e.g. catamenial tampons; Accessories therefor characterised by the material or the structure of the inner absorbing core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)

Abstract

La invencion proporciona compuestos de acido hialuronico y derivados del mismo para evitar las infecciones urogenitales por una variedad de patogenos, asi como composiciones, articulos y metodos para tratar y evitar las infecciones urogenitales.
MXPA05009712A 2003-03-28 2004-03-19 Composiciones que comprenden acido hialuronico para la prevencion de infecciones urogenitales. MXPA05009712A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/401,522 US7238677B2 (en) 2003-03-28 2003-03-28 Prevention of urogenital infections
PCT/US2004/008431 WO2004093887A1 (en) 2003-03-28 2004-03-19 Compositions comprising hyaluronic acid for the prevention of urogenital infections

Publications (1)

Publication Number Publication Date
MXPA05009712A true MXPA05009712A (es) 2005-10-18

Family

ID=32989475

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05009712A MXPA05009712A (es) 2003-03-28 2004-03-19 Composiciones que comprenden acido hialuronico para la prevencion de infecciones urogenitales.

Country Status (9)

Country Link
US (1) US7238677B2 (es)
EP (1) EP1610799A1 (es)
KR (1) KR20050115909A (es)
CN (1) CN1758919A (es)
AU (1) AU2004231526A1 (es)
CA (1) CA2519164A1 (es)
MX (1) MXPA05009712A (es)
TW (1) TW200509948A (es)
WO (1) WO2004093887A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1199645C (zh) * 2002-08-13 2005-05-04 中国人民解放军第三军医大学 N－乙酰－d－氨基葡萄糖在制备治疗泌尿生殖道感染药物中的应用
US7238677B2 (en) 2003-03-28 2007-07-03 Kimberly-Clark Worldwide, Inc. Prevention of urogenital infections
US20060127459A1 (en) * 2004-12-15 2006-06-15 Lei Huang Urogenital infection inhibition
WO2006089167A1 (en) * 2005-02-18 2006-08-24 Cartilix, Inc. Glucosamine materials
US7745158B2 (en) 2005-12-14 2010-06-29 Kimberly-Clark Worldwide, Inc. Detection of secreted aspartyl proteases from Candida species
JP2009519805A (ja) * 2005-12-20 2009-05-21 エスセーアー・ハイジーン・プロダクツ・アーベー 新しい物品
JP5095421B2 (ja) * 2006-02-10 2012-12-12 生化学工業株式会社 真菌増殖抑制剤
EP2344121B1 (en) * 2008-10-23 2017-07-12 Henkel IP & Holding GmbH Vaginal pellets comprising debranched starch
US9241896B2 (en) 2008-12-19 2016-01-26 Ultragenyx Pharmaceutical Inc. Methods and formulations for treating sialic acid deficiencies
JP5777712B2 (ja) * 2010-07-13 2015-09-09 ウルトラジェニックス ファーマシューティカル インコーポレイテッド シアル酸欠乏症を治療するための方法および製剤
AU2012328874B2 (en) 2011-10-24 2017-08-31 Ultragenyx Pharmaceutical Inc. Sialic acid analogs
US8889655B2 (en) 2012-07-20 2014-11-18 Aegis Women's Health Technologies Compositions and methods for preventing infectious diseases in females
WO2014152154A1 (en) * 2013-03-14 2014-09-25 Church & Dwight Co., Inc. Aqueous lubricant composition
CN104666240B (zh) * 2013-11-26 2019-03-22 菲迪亚制药股份公司 具有水润和润滑活性的药物组合物
ITMI20131971A1 (it) * 2013-11-26 2015-05-27 Fidia Farmaceutici Composizioni farmaceutiche ad attività idratante e lubrificante
US10385085B2 (en) 2015-09-14 2019-08-20 Ultragenyx Pharmaceutical Inc. Crystal forms of sialic acid or salt or solvate thereof
US10660933B2 (en) 2015-10-29 2020-05-26 University Of Maryland, College Park Compositions and methods for inhibition of bacterial infections in human endocervix
US10548844B2 (en) * 2015-12-14 2020-02-04 Massachusetts Institute Of Technology pH-responsive mucoadhesive polymeric encapsulated microorganisms
IT201700030619A1 (it) * 2017-03-20 2018-09-20 Labomar S R L Composizioni topiche vaginali.
US11504263B2 (en) * 2018-09-14 2022-11-22 Garry Allan Hrushka Sanitary stoma system and method
IL292494A (en) * 2019-11-01 2022-06-01 Pfizer Preparations of Escherichia coli and their methods
CN111249444B (zh) * 2020-03-10 2023-04-07 西北大学 一种用于抑制白色念珠菌的制剂

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4051842A (en) 1975-09-15 1977-10-04 International Medical Corporation Electrode and interfacing pad for electrical physiological systems
US4141973A (en) 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
DE2626348C3 (de) 1976-06-11 1980-01-31 Siemens Ag, 1000 Berlin Und 8000 Muenchen Implantierbare Dosiereinrichtung
SE8001748L (sv) 1980-03-05 1981-09-06 Kaellenius Gunilla Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
US4383529A (en) 1980-11-03 1983-05-17 Wescor, Inc. Iontophoretic electrode device, method and gel insert
AU561067B2 (en) 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
JPH0830004B2 (ja) 1983-11-14 1996-03-27 コロンビア ラボラトリーズ インコーポレイテッド 生物接着性組成物およびそれにより治療する方法
US4725585A (en) 1985-04-26 1988-02-16 Pharmacia Ab Method of enhancing the host defense
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
US4784991A (en) 1986-03-14 1988-11-15 Bio-Technology General Corp. Heavy metal salts of hyaluronic acid and their use as antimicrobial agents
US4746504A (en) 1986-03-14 1988-05-24 Bio-Technology General Corp. Heavy metal salts of hyaluronic acid and their use as antimicrobial agents
US4855128A (en) 1988-01-14 1989-08-08 Warner-Lambert Company Saccharide inhibition of dental plaque
US5510418A (en) 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
US5002759A (en) 1989-07-25 1991-03-26 Colgate-Palmolive Company Oligosaccharide inhibition of Streptococcus pyogenes adhesion
US5605938A (en) 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
US5409902A (en) 1991-12-31 1995-04-25 Lever Brothers Company Oral hygiene compositions containing glyceroglycolipids as antiplaque compounds
MX9304638A (es) 1992-07-31 1994-05-31 Neose Pharm Inc Composicion para tratar e inhibir las ulceras gastricas y duodenales.
US5650432A (en) 1995-03-24 1997-07-22 Jlb, Inc. Method of treating or preventing non-viral microbial infection
US5401723A (en) 1992-12-02 1995-03-28 Colgate-Palmolive Company Glycoconjugate inhibition of Streptococcus pyrogenes adhesion
IT1263144B (it) 1993-02-04 1996-08-01 Lanfranco Callegaro Composizioni farmaceutiche comprendenti materiale spugnoso costituito da derivati esterei dell'acido ialuronico in associazione con altre sostanze farmacologicamente attive
JPH09504522A (ja) 1993-10-12 1997-05-06 グリコメド・インコーポレイテッド 細胞接着インヒビターの同定に有用なグリコ−ペプチドのライブラリー
US5514665A (en) 1993-12-30 1996-05-07 University Of British Columbia Method of preventing or reducing the risk of infection by bacterial pathogens utilizing simple and conjugated dextrans
ITPD940054A1 (it) 1994-03-23 1995-09-23 Fidia Advanced Biopolymers Srl Polisaccaridi solfatati
US5604200A (en) 1994-05-02 1997-02-18 Taylor-Mccord; Darlene Wound therapeutic mixture containing medical grade hyaluronic acid and tissue culture grade plasma-fibronectin in a delivery system that creates a moist environment which simulates in utero healing
IT1273742B (it) 1994-08-01 1997-07-09 Lifegroup Spa Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose
US5591724A (en) * 1995-02-14 1997-01-07 Bioniche Inc. Method for treating the urinary bladder and associated structures using hyaluronic acid
US6063773A (en) 1995-09-29 2000-05-16 Polydex Pharmaceuticals Ltd. Cellulose sulfate for use as antimicrobial and contraceptive agent
IT1276940B1 (it) 1995-10-16 1997-11-03 Baldacci Lab Spa Uso topico di acido ialuronico e bacillo di doderlein nella prevenzione e nel trattamento terapeutico di patologie vaginali
JPH09208476A (ja) 1996-01-26 1997-08-12 Takada Seiyaku Kk 腹腔内投与用医薬組成物
US5700458A (en) 1996-09-20 1997-12-23 Geltex Pharmaceuticals Inc. Acid-functionalized saccharides as polyvalent anti-infectives
IT1287967B1 (it) 1996-10-17 1998-09-10 Fidia Spa In Amministrazione S Preparazioni farmaceutiche per uso anestetico locale
US6290959B1 (en) 1996-10-24 2001-09-18 New York University Method for screening compounds for inhibiting bacterial attachment to host cell receptors
US5840322A (en) 1996-12-19 1998-11-24 Ramot-University Authority For Applied Research & Industrial Devel. Ltd. Anti-oral-microbial adhesion fraction derived from vaccinium
DE19813234A1 (de) 1998-03-26 1999-09-30 Knoell Hans Forschung Ev Verfahren zur Herstellung hochsulfatierter Hyaluronsäuren
FR2779351B1 (fr) 1998-06-04 2000-12-22 Ioltechnologie Production Dispositif d'administration de fluides viscoelastiques pour chirurgie intraoculaire
JP2002536323A (ja) 1999-02-04 2002-10-29 ジェンザイム コーポレーション 膿瘍形成の予防
US6375963B1 (en) 1999-06-16 2002-04-23 Michael A. Repka Bioadhesive hot-melt extruded film for topical and mucosal adhesion applications and drug delivery and process for preparation thereof
AU2001292943A1 (en) 2000-09-21 2002-04-02 The Brigham And Women's Hospital, Inc. Prevention and treatment of streptococcal and staphylococcal infection
JP2002238995A (ja) 2001-02-16 2002-08-27 Denki Kagaku Kogyo Kk 分離型医療材料
ITBO20010361A1 (it) 2001-06-07 2002-12-07 Farma Derma S R L Uso di acido ialuronico per la produzione di un preparato ad uso vaginale, in particolare per la cura degli stati atrofici e distrofici cerv
US20030204180A1 (en) 2002-04-30 2003-10-30 Kimberly-Clark Worldwide, Inc. Temperature responsive delivery systems
US7238677B2 (en) 2003-03-28 2007-07-03 Kimberly-Clark Worldwide, Inc. Prevention of urogenital infections
US20050095219A1 (en) 2003-10-29 2005-05-05 Shu-Ping Yang Compositions for promoting vaginal cell proliferation and maturation

Also Published As

Publication number Publication date
KR20050115909A (ko) 2005-12-08
CN1758919A (zh) 2006-04-12
US7238677B2 (en) 2007-07-03
EP1610799A1 (en) 2006-01-04
TW200509948A (en) 2005-03-16
US20040192642A1 (en) 2004-09-30
CA2519164A1 (en) 2004-11-04
AU2004231526A1 (en) 2004-11-04
WO2004093887A1 (en) 2004-11-04

Similar Documents

Publication Publication Date Title
MXPA05009712A (es) Composiciones que comprenden acido hialuronico para la prevencion de infecciones urogenitales.
PT1984357E (pt) Compostos de 2,4-pirimidinadiamina para tratamento ou prevenção de doenças autoimunes
MXPA05008126A (es) Inhibidores de girasa y uso de los mismos.
DE602004021472D1 (en) Pyrimiidinverbindungen
WO2006073457A3 (en) Bioactive compounds and methods of uses thereof
UA92355C2 (en) urn:schemas-microsoft-com:office:smarttags2,4-DIAMINO-PYRIMIDINES USED AS AURORAINHIBITORS
MY142018A (en) Thiophene derivatives as chk 1 inihibitors
TW200517381A (en) Bicyclic heteroaryl derivatives
TW200734344A (en) Antibacterial agents
MX2007007919A (es) Nuevos derivados de bencilaminas como inhibidores de la proteina de transferencia de colesteril-ester(cetp).
MX2007000505A (es) Derivados de oxindol sustituidos y medicamentos que contienen los mismos.
MXPA05011707A (es) Dihidroquinazolinas sustituidas con propiedades antivirales.
MXPA05009969A (es) Metodo para aislar la forma cristalina i de la 5-azacitidina.
UA88645C2 (ru) Гетероарильные соединения как бета-миметики для лечения заболеваний дыхательных путей
WO2007067559A3 (en) Antibacterial agents
TW200510405A (en) Bridged n-arylsulfonylpiperidines as gamma-secretase inhibitors
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
ZA200701629B (en) Gyrase inhibitors and uses thereof
GB0321003D0 (en) Compounds, compositions and uses
WO2006120563A3 (en) Antibacterial agents
TW200510317A (en) Caspase inhibitors and uses thereof
TW200700071A (en) Novel use
WO2006128089A3 (en) Compositions and methods for treating tissue
PL371127A1 (en) 6-aminomorphinane derivatives, method for the production and use thereof
NZ545472A (en) 7-(4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl)quinolonecarboxylic acid derivative